 BASEL, Switzerland, Sept. 02, 2022 GLOBE NEWSWIRE -- Myovant Sciences NYSE: MYOV, a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy, today announced that David Marek, Chief Executive Officer of Myovant Sciences, Inc., and Uneek Mehra, Chief Financial and Business Officer, will participate in the following upcoming investor conferences: 